CellSource

Shibuya, Japan Founded: 2015 • Age: 11 yrs
Biopharma business consulting services are provided to industry clients.
Annual revenue $27.8M Latest available
Total funding - Funding intelligence
Employees 157 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About CellSource

CellSource is a company based in Shibuya (Japan) founded in 2015. The company has 157 employees as of October 31, 2024. CellSource operates in a competitive market with competitors including Vitalic, Beghou Consulting, Ewopharma, SMSRC and ProcDNA, among others.

  • Headquarter Shibuya, Japan
  • Employees 157 as on 31 Oct, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Cellsource Co., Ltd.
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $27.78 M (USD)
    -3.45
    as on Oct 31, 2024
  • Net Profit
    $1.52 M (USD)
    -74.22
    as on Oct 31, 2024
  • EBITDA
    $1.8 M (USD)
    -78.07
    as on Oct 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    157

    as on Oct 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of CellSource

CellSource is a publicly listed company on the TSE with ticker symbol 4880 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TSE · Ticker: 4880 · Sector: Health technology · Japan

Funding Insights of CellSource

Premium access

Detailed funding history for CellSource

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CellSource

Investments
Premium access

Investment portfolio details for CellSource

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - CellSource

Premium access

Detailed financials for CellSource

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cellsource Comparisons

CellSource Primary company
Description
Biopharma business consulting services are provided to indus...
Location
Shibuya, Japan
Founded Year
2015
Annual Revenue
$27.78 M (USD)
Net Profit
$1.52 M (USD)
EBITDA
$1.8 M (USD)
Employees
157
As of 2024
Premium access

Peer comparison for CellSource

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CellSource

CellSource operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vitalic, Beghou Consulting, Ewopharma, SMSRC and ProcDNA, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharma distribution, sales, and business support services are provided.
Locked Locked Locked
Provider of data analytics and market research services to biopharma sector
Locked Locked Locked
Ewopharma is engaged in pharmaceutical market access in Central and Eastern Europe.
Locked Locked Locked
Offers strategic consulting, Rx data analytics, and software for pharmaceutical industry growth.
Locked Locked Locked
Offers research content, innovations, and insights to empower business decision-making.
Premium access

Detailed competitors of CellSource

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cellsource

TABLE-Cellsource -Q1 group results
Reuters4 months ago
TABLE-Cellsource -2024/25 group results
Reuters7 months ago
Premium access

Complete news archive for CellSource

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CellSource

CellSource was founded in 2015.

CellSource is headquartered in Shibuya, Japan. It is registered at Shibuya, Tokyo, Japan.

As of Oct 31, 2024, the latest employee count at CellSource is 157.

Annual revenue of CellSource is $27.78M as on Oct 31, 2024.

CellSource was founded in 2015 and is based in Shibuya, Japan. Biopharmaceutical sector consulting is offered, with a focus on business strategy and operations support. Services include advisory on market analysis, regulatory compliance, and partnership development for biopharma firms. Operations are conducted primarily within Japan, serving domestic and international clients in the life sciences industry. The firms domain is cellsource.co.jp.

CellSource's top competitors include Vitalic, Beghou Consulting and D Cube Analytics.

Yes, CellSource is publicly traded on TSE under the ticker symbol 4880.

The ticker symbol of CellSource is 4880 on TSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available